Lv1
60 积分 2021-03-28 加入
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival
5天前
已完结
2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial
4个月前
已完结
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial
5个月前
已完结
疼痛评估量表应用的中国专家共识（2020版）
7个月前
已完结
Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases
10个月前
已完结
188 Re Zoledronic Acid in the Palliative Treatment of Painful Bone Metastases
10个月前
已完结
[Chinese expert consensus of albumin-bound paclitaxel in the treatment of breast cancer]
1年前
已完结
Behavioural research, the Museum Darwinianum and evolutionism in early Soviet Russia
1年前
已关闭
[Expert consensus on the management of adverse events of CDK4/6 inhibitors in breast cancer]
1年前
已完结
皖公网安备34019202002308
